Description
VENTAVIS 252MG TOTAL
First action · last action
2008-02-15 · 2008-02-15
Transactions
1
First transaction's obligation
$51,222
Base + all options value (sum of deltas)
$51,222
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-02-15+$51,222= $51,222
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-02-15 | +$51,222 | $51,222 | VENTAVIS 252MG TOTAL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Y12HDHECA8F6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0910 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $39,143 | FY2026 |
| 36C24226P0796 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $38,875 | FY2026 |
| 36C24526P0495 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $38,098 | FY2026 |
| 36C24526P0464 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $38,098 | FY2026 |
| 36C24226P0716 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $38,875 | FY2026 |
| 36C24226P0660 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $38,875 | FY2026 |
Other recipients under 6505 from 603S-LOUISVILLE SMALL PURCHASE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V603U10882 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 603S-LOUISVILLE SMALL PURCHASE | $6,572 | FY2011 |
| V603U10871 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 603S-LOUISVILLE SMALL PURCHASE | $4,381 | FY2011 |
| V603P17213 | BAYER HEALTHCARE PHARMACEUTICALS LIMITED LIABILITY COMPANY | 603S-LOUISVILLE SMALL PURCHASE | $3,218 | FY2011 |
| V603U10796 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 603S-LOUISVILLE SMALL PURCHASE | $6,630 | FY2011 |
| V603U10791 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 603S-LOUISVILLE SMALL PURCHASE | $4,151 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V603C80210_3600_-NONE-_-NONE- · retrieved 2026-09-26.